Ulta Beauty Stocks Dip Amid Investors’ Jitters Ulta Beauty Stocks Dip Amid Investors’ Jitters

JJ Bounty



Shares of Ulta Beauty, Inc. ULTA fell sharply during
Wednesday’s session amid the company’s presentation at the J.P. Morgan Retail Roundup investor conference
where the company reportedly issued a weak outlook.


Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.


Here are some other stocks moving in today’s mid-day session.


Gainers


  • ARCA biopharma, Inc. ABIO climbed 108% to $3.5549 after the
    company and Oruka Therapeutics announced a merger agreement.
  • Kintara Therapeutics, Inc. KTRA shares gained 89% to $0.1906 after
    the company entered a merger agreement with TuHURA Biosciences.
  • Next Technology Holding Inc. NXTT rose 57.4% to $6.42.
  • Vanda Pharmaceuticals Inc. VNDA shares climbed 39.3% to $5.45. Vanda
    Pharmaceuticals’ Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I
    Disorder.
  • VivoPower International PLC VVPR shares gained 39% to $8.20 after the
    company declared a capital management strategy including a stock buyback program of up to $5
    million.
  • Next.e.GO N.V. EGOX gained 32.7% to $0.0345.
  • XTI Aerospace, Inc. XTIA rose 32.2% to $4.63.
    BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc.
  • Brooge Energy Limited BROG gained 28.8% to $3.0790.
  • Addex Therapeutics Ltd ADXN rose 24.6% to $16.21 after the company
    and funds affiliated with Perceptive Advisors announced the launch of Neurosterix.
  • Aesthetic Medical International Holdings Group Limited AIH gained
    24.3% to $0.3981 after gaining 13% on Tuesday.
  • LAMF Global Ventures Corp. I LGVC gained 22.7% to $13.21. ViewLAMF
    Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group
    Ltd.
  • Quhuo Limited QH rose 21.7% to $0.6501 after reporting unaudited financial
    results for the second half and full year 2023.
  • Destiny Tech100 Inc. DXYZ gained 21.4% to $25.77.
  • OneMedNet Corporation ONMD gained 21.2% to $0.9600. OneMedNet
    announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in
    funding through private placement of senior convertible notes.
  • CXApp Inc. CXAI gained 20.5% to $5.40 following a massive rally to start
    the week. CXApp shares rallied more than 150% to start the week after the company announced a
    partnership with Alphabet’s Google Cloud.
  • Clean Energy Technologies, Inc. CETY climbed 20.5% to $1.63.
  • American Battery Technology Company ABAT rose 17.7% to $1.9301. American
    Battery Technology Company was awarded $20 million tax credit through competitive U.S. DOE process to
    advance its critical minerals battery recycling facility.
  • C3is Inc. CISS shares rose 14.9% to $0.0470 after gaining 13% on Tuesday.
    On March 26, C3is reported a year-over-year increase in fourth-quarter financial results.
  • Pyxis Oncology, Inc. PYXS gained 12.3% to $6.04.
  • Atai Life Sciences N.V. ATAI surged 11.4% to $2.08. Maxim Group
    analyst Jason McCarthy upgraded ATAI Life Sciences from Hold to Buy and announced a $6 price target.
  • Dave & Buster’s Entertainment, Inc. PLAY shares rose 10.2% to $68.22 after
    the company reported fourth quarter results.
  • Esperion Therapeutics, Inc. ESPR jumped 9.7% to $3.16.
  • Signet Jewelers Limited SIG gained 9.2% to $103.80after the company
    raised its FY25 guidance.
  • Inspire Veterinary Partners, Inc. IVP gained 9% to $0.0512. On Jan. 5,
    Inspire Veterinary Partners filed a prospectus related to up to a $5 million public offering.
  • Semtech Corporation SMTC gained 7.4% to $30.28.
  • Cal-Maine Foods, Inc. CALM climbed 6.8% to $62.88 after the
    company reported upbeat results for its fourth quarter.


Losers


  • Casa Systems, Inc. CASA shares dipped 78.1% to $0.0563 after the Company filed voluntary
See also  The Transformation of Enterprises: Embracing Cloud for Integrated AI and Data Platforms

Market Turmoil: A Dive into Recent Stock Plummets

  • View, Inc.: A Road to Private Ownership

    View, Inc. plunged 61.9% to $0.4196 after filing for Chapter 11 bankruptcy, steering towards a private future through an agreement with Cantor Fitzgerald and RXR.

  • Sintx Technologies, Inc.: Public Offering Woes

    Sintx Technologies, Inc. tumbled 44.5% to $0.0232 with the pricing of a $1.5 million public offering of common stock.

  • GCT Semiconductor Holding, Inc.: Topsy-Turvy Ride

    GCT Semiconductor Holding, Inc. dipped 40% to $9.29 amidst volatility after merging with Concord Acquisition Corp III and debuting on the NYSE.

  • FibroGen, Inc.: Clinical Trial Setback

    FibroGen, Inc. saw a 32.8% decrease to $1.4499 following disappointing topline data from a Phase 1 study, dampening hopes for a potential anti-CD46 antibody drug.

  • Keyarch Acquisition Corporation: Plummeting Shares

    Keyarch Acquisition Corporation fell 28.5% to $9.65, shaking investor confidence in the company’s trajectory.

  • TRACON Pharmaceuticals, Inc.: Trial Update Fallout

    TRACON Pharmaceuticals, Inc. dipped 24.2% to $0.3148 post an update on the ENVASARC Phase 2 trial, proceeding as recommended by the Independent Data Monitoring Committee.

  • BYND Cannasoft Enterprises Inc.: Rollercoaster Drop

    BYND Cannasoft Enterprises Inc. fell 22.5% to $0.9741 after a previous 12% decline, reflecting a tumultuous period for the company.

  • Anghami Inc.: Completed Transaction Aftershock

    Anghami Inc. tumbled 22.2% to $1.40 after its transaction with OSN+, signaling unease among investors.

  • Locafy Limited: Earnings Report Impact

    Locafy Limited dropped 21.9% to $3.67 following disappointing second-quarter results, echoing challenges within the company.

  • Vicinity Motor Corp.: EPS Decline

    Vicinity Motor Corp. slid 19.3% to $0.75 post a year-over-year decrease in fourth-quarter EPS, raising concerns among shareholders.

  • Enveric Biosciences, Inc.: Market Hit

    Enveric Biosciences, Inc. experienced an 18.4% drop to $0.93, facing repercussions from market volatility.

  • Murano Global Investments Plc: Steep Decline

    Murano Global Investments Plc fell 16.8% to $10.39, underscoring challenges in the investments landscape.

  • Critical Metals Corp.: Market Pressure

    Critical Metals Corp. witnessed a 16.7% decline to $11.66, reflecting wider market trends affecting metal investments.

  • Acorda Therapeutics, Inc.: Bankruptcy Proceedings

    Acorda Therapeutics, Inc. shares plummeted 12% to $2.20 as the company initiated voluntary Chapter 11 proceedings, marking a significant turn in its financial journey.

  • Exscientia plc: Quarterly Disappointment

    Exscientia plc fell 10.8% to $4.6395 after quarterly results fell short, raising concerns among investors.

  • Gamida Cell Ltd.: Volatile Performance

    Gamida Cell Ltd. shares fell 8.4% to $0.0403 post a significant gain, reflecting the unpredictable nature of the market.

  • e.l.f. Beauty, Inc.: Peer Influence

    e.l.f. Beauty, Inc. declined 8.2% to $170.71 following weak guidance from industry peer Ulta Beauty, signaling a broader industry challenge.

  • NWTN Inc.: Market Correction

    NWTN Inc. fell 8% to $7.21, reflecting a market-wide correction affecting tech stocks.

  • Mesoblast Limited: Volatility Continues

    Mesoblast Limited shares tumbled 7.3% to $6.11 post a previous gain, demonstrating ongoing uncertainty in the market.

  • Applied Digital Corporation: Stock Decline

    Applied Digital Corporation fell 6.1% to $3.5850, signaling challenges ahead for the digital solutions company.

  • Lands’ End, Inc.: Market Fluctuations

    Lands’ End, Inc. dropped 6.1% to $11.25, indicating broader market fluctuations affecting retail stocks.

  • Intel Corporation: Financial Strategy Shift

    Intel Corporation fell 6.1% to $41.27 after unveiling a new financial reporting structure for its foundry business, aiming for enhanced transparency and cost discipline to drive higher returns.